BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Panatto D, Signori A, Lai PL, Gasparini R, Amicizia D. Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis. Influenza Other Respir Viruses 2018;12:533-43. [PMID: 29498477 DOI: 10.1111/irv.12550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bellino S, Piovesan C, Bella A, Rizzo C, Pezzotti P, Ramigni M. Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons. Hum Vaccin Immunother 2020;16:301-12. [PMID: 31486347 DOI: 10.1080/21645515.2019.1661754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Pițigoi D, Streinu-Cercel A, Ivanciuc AE, Lazãr M, Cherciu CM, Mihai ME, Nițescu M, Aramă V, Crăciun MD, Streinu-Cercel A, Săndulescu O. Surveillance of medically-attended influenza in elderly patients from Romania-data from three consecutive influenza seasons (2015/16, 2016/17, and 2017/18). Influenza Other Respir Viruses 2020;14:530-40. [PMID: 32410402 DOI: 10.1111/irv.12752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’agnano V, Komici K, Mazzarella G, Parrella R, Bianco A. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 2020;32:1599-608. [DOI: 10.1007/s40520-020-01631-y] [Cited by in Crossref: 155] [Cited by in F6Publishing: 124] [Article Influence: 77.5] [Reference Citation Analysis]
4 Tramuto F, Restivo V, Costantino C, Colomba GME, Maida CM, Casuccio A, Vitale F. Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy. Am J Trop Med Hyg 2019;101:1232-9. [PMID: 31571567 DOI: 10.4269/ajtmh.19-0059] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Baral N, Adhikari P, Adhikari G, Karki S. Influenza Myocarditis: A Literature Review. Cureus 2020;12:e12007. [PMID: 33437555 DOI: 10.7759/cureus.12007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Song JY, Lee J, Woo HJ, Wie SH, Lee JS, Kim SW, Kim TH, Jung SI, Noh JY, Choi WS, Cheong HJ, Kim WJ. Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults. Hum Vaccin Immunother 2019;15:710-6. [PMID: 30396317 DOI: 10.1080/21645515.2018.1536589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Lapi F, Marconi E, Simonetti M, Baldo V, Rossi A, Sessa A, Cricelli C. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly. Expert Rev Vaccines 2019;18:663-70. [PMID: 31155968 DOI: 10.1080/14760584.2019.1622418] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
8 Sun W, Kirkpatrick E, Ermler M, Nachbagauer R, Broecker F, Krammer F, Palese P. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach. J Virol 2019;93:e00333-19. [PMID: 30944178 DOI: 10.1128/JVI.00333-19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
9 de Waure C, Boccalini S, Bonanni P, Amicizia D, Poscia A, Bechini A, Barbieri M, Capri S, Specchia ML, Di Pietro ML, Arata L, Cacciatore P, Panatto D, Gasparini R. Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment. Eur J Public Health 2019;29:900-5. [PMID: 30929026 DOI: 10.1093/eurpub/ckz041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Loperto I, Simonetti A, Nardone A, Triassi M. Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence. Hum Vaccin Immunother 2019;15:1035-47. [PMID: 30735465 DOI: 10.1080/21645515.2019.1578597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Sun W, Kang DS, Zheng A, Liu STH, Broecker F, Simon V, Krammer F, Palese P. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans. J Virol 2019;93:e01673-18. [PMID: 30381487 DOI: 10.1128/JVI.01673-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
12 O’neil B, Ison MG, Hallouin-bernard M, Nilsson AC, Torres A, Wilburn JM, van Duijnhoven W, Van Dromme I, Anderson D, Deleu S, Kosoglou T, Vingerhoets J, Rossenu S, Leopold L. A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study. The Journal of Infectious Diseases 2020. [DOI: 10.1093/infdis/jiaa376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Panatto D, Signori A, Lai PL, Gasparini R, Amicizia D. Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis. Influenza Other Respir Viruses 2018;12:533-43. [PMID: 29498477 DOI: 10.1111/irv.12550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]